These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 25976245)

  • 1. Molecular and Genomic Alterations in Glioblastoma Multiforme.
    Crespo I; Vital AL; Gonzalez-Tablas M; Patino Mdel C; Otero A; Lopes MC; de Oliveira C; Domingues P; Orfao A; Tabernero MD
    Am J Pathol; 2015 Jul; 185(7):1820-33. PubMed ID: 25976245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [OMICS and biomarkers of glial tumors].
    Idbaih A
    Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
    Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
    J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new method of identifying glioblastoma subtypes and creation of corresponding animal models.
    Zhou X; Li G; An S; Li WX; Yang H; Guo Y; Dai Z; Dai S; Zheng J; Huang J; Iavarone A; Zhao X
    Oncogene; 2018 Aug; 37(35):4781-4791. PubMed ID: 29769617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.
    Charest A; Wilker EW; McLaughlin ME; Lane K; Gowda R; Coven S; McMahon K; Kovach S; Feng Y; Yaffe MB; Jacks T; Housman D
    Cancer Res; 2006 Aug; 66(15):7473-81. PubMed ID: 16885344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development.
    Brown KE; Chagoya G; Kwatra SG; Yen T; Keir ST; Cooter M; Hoadley KA; Rasheed A; Lipp ES; Mclendon R; Ali-Osman F; Bigner DD; Sampson JH; Kwatra MM
    J Neurochem; 2015 Jun; 133(5):730-8. PubMed ID: 25598002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma: pathology, molecular mechanisms and markers.
    Aldape K; Zadeh G; Mansouri S; Reifenberger G; von Deimling A
    Acta Neuropathol; 2015 Jun; 129(6):829-48. PubMed ID: 25943888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers.
    Korshunov A; Ryzhova M; Hovestadt V; Bender S; Sturm D; Capper D; Meyer J; Schrimpf D; Kool M; Northcott PA; Zheludkova O; Milde T; Witt O; Kulozik AE; Reifenberger G; Jabado N; Perry A; Lichter P; von Deimling A; Pfister SM; Jones DT
    Acta Neuropathol; 2015 May; 129(5):669-78. PubMed ID: 25752754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network analysis of genomic alteration profiles reveals co-altered functional modules and driver genes for glioblastoma.
    Gu Y; Wang H; Qin Y; Zhang Y; Zhao W; Qi L; Zhang Y; Wang C; Guo Z
    Mol Biosyst; 2013 Mar; 9(3):467-77. PubMed ID: 23344900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor tyrosine kinase-Ras-PI 3 kinase-Akt signaling network in glioblastoma multiforme.
    Tuncel G; Kalkan R
    Med Oncol; 2018 Aug; 35(9):122. PubMed ID: 30078108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma.
    Rahme GJ; Luikart BW; Cheng C; Israel MA
    Neuro Oncol; 2018 Feb; 20(3):332-342. PubMed ID: 29016807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
    Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
    Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt.
    Uhrbom L; Dai C; Celestino JC; Rosenblum MK; Fuller GN; Holland EC
    Cancer Res; 2002 Oct; 62(19):5551-8. PubMed ID: 12359767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF; Miller DC; Koslow M; Newcomb EW
    J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DNA methylome of glioblastoma multiforme.
    Martinez R; Esteller M
    Neurobiol Dis; 2010 Jul; 39(1):40-6. PubMed ID: 20064612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioinformatic analyses reveal the key pathways and genes in the CXCR4 mediated mesenchymal subtype of glioblastoma.
    Yi L; Tong L; Li T; Hai L; Abeysekera IR; Tao Z; Ma H; Liu P; Xie Y; Li J; Yuan F; Yu S; Yang X
    Mol Med Rep; 2018 Jul; 18(1):741-748. PubMed ID: 29767255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Established and emerging variants of glioblastoma multiforme: review of morphological and molecular features.
    Karsy M; Gelbman M; Shah P; Balumbu O; Moy F; Arslan E
    Folia Neuropathol; 2012; 50(4):301-21. PubMed ID: 23319187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry.
    Purkait S; Jha P; Sharma MC; Suri V; Sharma M; Kale SS; Sarkar C
    Neuropathology; 2013 Aug; 33(4):405-12. PubMed ID: 23311918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations.
    Brennan C; Momota H; Hambardzumyan D; Ozawa T; Tandon A; Pedraza A; Holland E
    PLoS One; 2009 Nov; 4(11):e7752. PubMed ID: 19915670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date.
    Bastien JI; McNeill KA; Fine HA
    Cancer; 2015 Feb; 121(4):502-16. PubMed ID: 25250735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.